Letters
Reference drug pricing
Sebastian Schneeweiss, Stephen B. Soumerai and Malcolm Maclure
CMAJ July 23, 2002 167 (2) 126-127;
Sebastian Schneeweiss
*Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; †Drug Policy Research Group, Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, MA; School of Health Information Science, University of Victoria, Victoria, BC
Stephen B. Soumerai
*Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; †Drug Policy Research Group, Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, MA; School of Health Information Science, University of Victoria, Victoria, BC
Malcolm Maclure
*Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; †Drug Policy Research Group, Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, MA; School of Health Information Science, University of Victoria, Victoria, BC
In this issue
Article tools
Reference drug pricing
Sebastian Schneeweiss, Stephen B. Soumerai, Malcolm Maclure
CMAJ Jul 2002, 167 (2) 126-127;
Jump to section
Related Articles
- No related articles found.